A peptoid is a synthetic molecule that mimics the structure of a natural peptide but with one critical difference: the side chains that give each unit its chemical identity are attached to the nitrogen atom of the backbone rather than the carbon atom. This seemingly small shift has large consequences. Peptoids resist breakdown by the enzymes that chew through natural peptides, they slip into cells more easily, and they can be assembled from a vast library of cheap building blocks. First developed in the early 1990s as tools for drug discovery, peptoids have since expanded into antimicrobial development, diagnostic platforms, and even materials science.
How a Peptoid Differs from a Peptide
Natural peptides are short chains of amino acids linked by amide bonds. Each amino acid has a side chain hanging off the alpha-carbon of the backbone, and the nitrogen in the backbone carries a hydrogen atom. That hydrogen is important: it participates in the hydrogen bonds that stabilize familiar protein structures like alpha-helices and beta-sheets. In a peptoid, the side chain has been moved from the alpha-carbon to the backbone nitrogen, replacing that hydrogen. The result is a chain of N-substituted glycine units rather than conventional amino acids.
Because the backbone nitrogen no longer carries a hydrogen, peptoids cannot form the same internal hydrogen bonds that peptides rely on to fold. Yet peptoids can still adopt stable, helix-like structures. Research has shown that peptoid oligomers with bulky, chiral side chains fold into stable helices in both organic and water-based solutions, despite having no backbone chirality and no capacity for internal hydrogen bonding.1PubMed. Peptoid oligomers with alpha-chiral, aromatic side chains: effects of chain length on secondary structure The folding is driven mainly by steric interactions between those bulky side chains, which push the backbone into preferred conformations.2PubMed. Peptoid oligomers with alpha-chiral, aromatic side chains: sequence requirements for the formation of stable peptoid helices This is a fundamentally different folding engine than the one proteins use, and it means peptoid designers can shape three-dimensional structure through side-chain choice alone.
Another consequence of the shifted side chain is that the amide bond in the backbone can flip between two orientations more freely than in peptides. NMR spectroscopy and computational studies have confirmed that these cis-trans rotamer preferences in peptoids are influenced by electronic interactions between the backbone and certain side chains, providing another lever for controlling shape.3PubMed. Cis-trans amide bond rotamers in β-peptoids and peptoids: evaluation of stereoelectronic effects in backbone and side chains
How Peptoids Are Made
One of the most practical things about peptoids is how straightforward they are to synthesize. The standard approach, known as the submonomer method, builds the peptoid chain one unit at a time on a solid support (a tiny resin bead). Each monomer addition involves just two chemical steps. First, bromoacetic acid is activated and used to attach a reactive handle to the growing chain. Second, a primary amine is added, which kicks out the bromide and installs the desired side chain. This two-step cycle repeats until the chain reaches the target length.4PubMed Central. Solid-phase submonomer synthesis of peptoid polymers and their self-assembly into highly-ordered nanosheets
The efficiency of each cycle routinely exceeds 98%, which means chains of 50 or more units can be produced before cumulative losses become a problem.4PubMed Central. Solid-phase submonomer synthesis of peptoid polymers and their self-assembly into highly-ordered nanosheets A practical ceiling of roughly 60 monomer units has been noted, since even small per-step losses compound over many cycles.5ACS Polymers Au. A Field Guide to Optimizing Peptoid Synthesis – Section: 2.1. Submonomer Protocols
A major selling point of this method is the diversity of available building blocks. Because each side chain is introduced simply by choosing a different primary amine, and thousands of primary amines are commercially available, researchers can explore an enormous chemical space without needing to design and protect specialized monomers the way peptide chemists often must.5ACS Polymers Au. A Field Guide to Optimizing Peptoid Synthesis – Section: 2.1. Submonomer Protocols This accessibility made peptoids one of the earliest platforms for combinatorial chemistry: generating large libraries of structurally diverse molecules and screening them for useful activity.
Why Peptoids Survive Where Peptides Do Not
Natural peptides face a fundamental problem as drug candidates: the body is very good at breaking them down. Enzymes called proteases recognize the backbone of natural peptides and clip the amide bonds. Because peptoids have their side chains on nitrogen rather than carbon, the backbone looks unfamiliar to these enzymes. Proteases struggle to bind and cut it. This improved resistance to enzymatic degradation is one of the strongest arguments for using peptoids in therapeutic applications.6ScienceDirect. Recent advances in the development of therapeutic peptides – Section: Peptoids
The same structural shift that blocks proteases also reduces the molecule’s tendency to form hydrogen bonds with surrounding water. Counterintuitively, this is an advantage for getting into cells. A comparative study of matched peptoid and peptide sequences showed that peptoids consistently crossed cell membranes more effectively, and the researchers attributed the improvement primarily to this reduction in hydrogen-bonding potential.7PubMed Central. High-throughput evaluation of relative cell permeability between peptoids and peptides Separate work on chimeric molecules containing both peptide and peptoid segments found that versions carrying guanidinium groups were taken up by cells about four times more efficiently than the well-known cell-penetrating peptide Tat.8Biochimica et Biophysica Acta (BBA) – Biomembranes. Cellular uptake and membrane-destabilising properties of α-peptide/β-peptoid chimeras: lessons for the design of new cell-penetrating peptides
Stability and permeability together mean that a peptoid-based drug could survive longer in the bloodstream and reach its intracellular target more reliably than a comparable peptide. These properties also make peptoids attractive for screening large combinatorial libraries, since the molecules that emerge from screening are already resistant to breakdown and more likely to be biologically available.
Fighting Bacteria with Peptoids
Antimicrobial activity is one of the most active areas of peptoid research, driven by the urgent need for alternatives to conventional antibiotics. Many natural antimicrobial peptides kill bacteria by disrupting their cell membranes, but those peptides are rapidly degraded in the body. Peptoids can be designed to mimic the charge-and-hydrophobicity pattern of these natural killers while dodging enzymatic destruction.
Self-assembling peptoids have been shown to kill both Gram-positive and Gram-negative bacteria through a membrane-disruption mechanism. Transmission electron microscopy and membrane-depolarization assays confirmed that these peptoids physically compromise bacterial membranes.9PubMed. Self-Assembling and Pore-Forming Peptoids as Antimicrobial Biomaterials But membrane disruption is not always the whole story. Studies on the peptoid known as TM1 and its analogues demonstrated that they permeabilize bacterial membranes within five minutes and then go on to aggregate intracellular targets like ribosomes and DNA, working faster than the important human antimicrobial peptide LL-37.10PubMed Central. Antimicrobial peptoids pass rapidly through bacterial membranes and flocculate ribosomes and DNA: A single-cell fluorescence study This dual mechanism, combining membrane disruption with intracellular targeting, may make it harder for bacteria to develop resistance.
Researchers have also been exploring hybrid molecules that blend peptide and peptoid segments. One study tested a series of peptide/β-peptoid hybrids against both wild-type and drug-resistant strains of E. coli and Acinetobacter baumannii. The hybrids retained strong antibacterial activity with minimum inhibitory concentrations in the low microgram-per-milliliter range, and all compounds in the series caused less than 10% damage to red blood cells at concentrations well above the therapeutic range, suggesting a useful safety margin.11PubMed Central. Peptide/β-Peptoid Hybrids with Ultrashort PEG-Like Moieties: Effects on Hydrophobicity, Antibacterial Activity and Hemolytic Properties The ability to tune selectivity, hitting bacterial cells while sparing human cells, is one of the central challenges in antimicrobial design, and the peptoid platform provides many knobs to turn.
Beyond Antimicrobials
Peptoids are being developed for several other biomedical roles. One early and striking application is in diagnostics. Microarrays containing thousands of different peptoid sequences can serve as protein “fingerprinting” tools. When a protein sample is washed over the array, each protein produces a reproducible binding pattern across the peptoid spots, allowing identification without needing to label the protein first. This approach has been demonstrated with multiple proteins and works with native, unlabeled samples detected through secondary antibody binding.12PubMed Central. Protein “fingerprinting” in complex mixtures with peptoid microarrays The idea is that such arrays could eventually be used in diagnostic settings where identifying proteins in complex biological mixtures matters.
Peptoids have also entered the imaging space. A proof-of-principle study demonstrated a peptoid-based tracer for positron emission tomography (PET) that could image VEGFR expression in a prostate cancer model, opening the door to using peptoids as targeted imaging agents in personalized medicine.13PubMed Central. Peptoid and Positron Emission Tomography: an Appealing Combination
On the therapeutic design front, researchers have used peptoid substitutions to gain selectivity among closely related enzyme targets. In one study, incorporating peptoid residues into collagen-like substrates produced a chimeric molecule that was efficiently cleaved by only one of several tested matrix metalloproteinases (MMP-13), rather than being processed indiscriminately by all of them. The selectivity arose not from sequence recognition but from specific interactions between the peptoid residue and a domain of MMP-13.14PubMed Central. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates This kind of precision engineering of enzyme selectivity is difficult to achieve with natural peptides alone and illustrates how the expanded chemical vocabulary of peptoids opens up design possibilities.
Peptoid Nanomaterials
Peptoids are not limited to individual molecules floating in solution. Because their sequences can be precisely controlled and they can carry both water-loving and water-repelling side chains, certain peptoids spontaneously organize into ordered two-dimensional structures. These peptoid nanosheets form at interfaces, such as between air and water or oil and water, where the amphiphilic peptoid chains first assemble into a monolayer and then compress into a bilayer.15PubMed Central. Assembly and molecular order of two-dimensional peptoid nanosheets through the oil-water interface Electrostatic interactions between charged residues on the peptoid, such as carboxylate and ammonium groups, are essential for the sheets to achieve their high degree of order.
These nanomaterials have been put to work. One particularly creative application involves assembling crystalline peptoid nanosheets and nanotubes that mimic carbonic anhydrase, the enzyme responsible for interconverting carbon dioxide and bicarbonate. By incorporating metal-binding ligands into self-assembling peptoid sequences, researchers created nanomaterials that catalyze CO₂ hydration and sequestration at rates comparable to the natural bovine enzyme.16PubMed Central. Assembled peptoid crystalline nanomaterials as carbonic anhydrase mimics for promoted hydration and sequestration of CO2 Metal-free versions of these enzyme-mimicking nanomaterials have also been developed, using a histidine-inspired functionality within a macrocyclic scaffold to achieve similar catalytic effects without relying on metal cations.17Advanced Functional Materials. Self‐Assembled Crystalline Peptoid Nanomaterials as Metal‐Free Enzyme Mimics for Enhanced Carbon Dioxide Hydration and Precipitation
Another materials application addresses the problem of biofouling, the unwanted accumulation of proteins, cells, and organisms on surfaces. Peptoid-based polymers anchored to surfaces using a mussel-inspired adhesive peptide have demonstrated dramatic reductions in protein adsorption and resistance to mammalian cell attachment lasting over five months in laboratory tests.18PubMed. New peptidomimetic polymers for antifouling surfaces A related approach drew inspiration from the sugar-coated glycoproteins that line cell surfaces, creating glycopeptoids that similarly blocked attachment of proteins, fibroblasts, and bacteria when grafted onto a solid surface.19PubMed Central. Antifouling glycocalyx-mimetic peptoids These antifouling coatings have potential in medical devices, marine surfaces, and industrial equipment.
Designing Peptoids by Computer
As the peptoid field matures, computational tools are catching up to the experimental ones. Designing a peptoid that folds into a specific shape requires knowing what conformations each side chain prefers when attached to different backbone geometries. Researchers have built rotamer libraries for peptoids, cataloguing the preferred side-chain orientations of 54 different peptoid building blocks using quantum mechanics and molecular mechanics calculations. These libraries have been integrated into the Rosetta molecular design software, and they accurately predict side-chain placements in experimentally solved peptoid structures.20PubMed Central. A rotamer library to enable modeling and design of peptoid foldamers
Computational structure prediction has also been validated for small peptoids. Molecular dynamics simulations of peptoid trimers showed that well-folded peptoids exhibit funnel-like energy landscapes similar to those seen in ordered natural polypeptides, meaning the molecule reliably settles into a single preferred shape rather than flopping between many equally stable alternatives.21PubMed Central. De novo structure prediction and experimental characterization of folded peptoid oligomers For the field, this is encouraging. It suggests that as computational power and force fields improve, it will become possible to design peptoids on a computer with confidence that the molecule will behave as predicted in the lab, much as protein engineers now do with natural amino acid sequences.
Where the Field Came From and Where It Struggles
Peptoids grew out of 1990s biotech and biopharma efforts to speed up drug discovery. The earliest combinatorial libraries of short peptoids were among the first demonstrations that high-affinity ligands for drug-relevant receptors could be discovered from synthetic compound libraries. The efficiency of the submonomer synthesis method then enabled the field to expand beyond drug discovery into diagnostics, drug delivery, and materials science. Structural biology milestones followed: first the peptoid helix, and much later the peptoid sheet, both close relatives of their natural protein counterparts.22PubMed. Peptoid origins
Despite decades of work, no peptoid has yet reached the market as an approved drug. Several challenges explain the gap. The same conformational flexibility that makes peptoids resistant to proteases also makes it harder to lock them into a single precise shape, which is often needed for tight binding to a specific protein target. The cis-trans isomerism of the backbone amide bond, while useful for some applications, can complicate efforts to achieve the kind of defined three-dimensional structure that traditional drug design relies on.23PubMed. Structural features of peptoid-peptide hybrids in lipid-water interfaces Additionally, while peptoids are resistant to enzymatic degradation, their pharmacokinetic profiles, including how they are absorbed, distributed, and cleared from the body, are still being mapped out in detail for many sequences.
The immunogenicity question is also nuanced. Peptoids are sometimes described as immunologically “invisible,” but this is an oversimplification. When a five-unit peptoid was conjugated to a carrier protein and injected into rabbits, it did elicit antibodies directed specifically against the peptoid portion of the molecule.24PubMed Central. The Immunogenicity of Peptoid-Protein Conjugates Whether free peptoids in typical therapeutic use would provoke a meaningful immune response remains an open question, but the blanket claim that peptoids cannot be recognized by the immune system does not hold up. For diagnostic applications, this immunogenicity is actually useful: the fact that specific anti-peptoid antibodies can be generated and used to retrieve particular peptoid-coated beads from a large library is a feature, not a bug.
Peptoid-Peptide Hybrids
Rather than choosing between a fully natural peptide and a fully synthetic peptoid, many researchers are working with hybrids that mix both types of residues in a single chain. The strategy is to keep the structural benefits of natural amino acids where they matter most, such as at a binding interface that has been optimized over evolutionary time, while substituting peptoid residues at positions vulnerable to protease attack. Inserting even a single peptoid monomer into an antimicrobial peptide increases its resistance to enzymatic cleavage, though it also introduces local conformational flexibility whose effect depends on where in the sequence the substitution is made.23PubMed. Structural features of peptoid-peptide hybrids in lipid-water interfaces
The collagen-mimetic peptomers mentioned earlier are another example: by placing peptoid residues at specific positions in a triple-helical collagen substrate, researchers achieved selective recognition by a single metalloproteinase out of four tested, a level of selectivity the all-natural sequence could not provide.14PubMed Central. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates Hybrids offer a middle path, gaining the protease resistance and expanded chemistry of peptoids without abandoning the structural precision that natural residues can deliver at critical positions. As the computational and experimental tools for predicting peptoid conformation improve, hybrid design is likely to become increasingly rational rather than trial-and-error.